[go: up one dir, main page]

BR9609460A - Lactobacilo microencapsulado para aplicações médicas - Google Patents

Lactobacilo microencapsulado para aplicações médicas

Info

Publication number
BR9609460A
BR9609460A BR9609460A BR9609460A BR9609460A BR 9609460 A BR9609460 A BR 9609460A BR 9609460 A BR9609460 A BR 9609460A BR 9609460 A BR9609460 A BR 9609460A BR 9609460 A BR9609460 A BR 9609460A
Authority
BR
Brazil
Prior art keywords
medical applications
microencapsulated lactobacillus
microencapsulated
lactobacillus
medical
Prior art date
Application number
BR9609460A
Other languages
English (en)
Inventor
Larry C Ford
Original Assignee
Lafor Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafor Lab Ltd filed Critical Lafor Lab Ltd
Publication of BR9609460A publication Critical patent/BR9609460A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
BR9609460A 1995-06-02 1996-05-31 Lactobacilo microencapsulado para aplicações médicas BR9609460A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/459,058 US5733568A (en) 1993-12-03 1995-06-02 Micro-encapsulated lactobacilli for medical applications
PCT/US1996/008260 WO1996038159A1 (en) 1995-06-02 1996-05-31 Micro-encapsulated lactobacilli for medical applications

Publications (1)

Publication Number Publication Date
BR9609460A true BR9609460A (pt) 1999-03-02

Family

ID=23823243

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609460A BR9609460A (pt) 1995-06-02 1996-05-31 Lactobacilo microencapsulado para aplicações médicas

Country Status (21)

Country Link
US (4) US5733568A (pt)
EP (1) EP0828499B1 (pt)
JP (1) JPH11506451A (pt)
KR (1) KR100478326B1 (pt)
CN (1) CN1100546C (pt)
AR (1) AR002754A1 (pt)
AT (1) ATE286737T1 (pt)
AU (1) AU702799B2 (pt)
BR (1) BR9609460A (pt)
CA (1) CA2222642C (pt)
DE (1) DE69634171T2 (pt)
EA (1) EA000412B1 (pt)
HU (1) HUP9900682A3 (pt)
IL (1) IL118304A (pt)
MX (1) MX9709318A (pt)
MY (1) MY120501A (pt)
NZ (1) NZ309456A (pt)
PL (1) PL323748A1 (pt)
TW (1) TW480174B (pt)
WO (1) WO1996038159A1 (pt)
ZA (1) ZA963810B (pt)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741525A (en) * 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
GB2310375A (en) * 1996-02-21 1997-08-27 Vanessa Clare Mcclafferty Pessaries for treating vaginal infections
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
RO113114B1 (ro) * 1997-08-05 1998-04-30 Rodica Teodorescu Produs eubiotic natural, pentru intretinerea si tratamentul tegumentelor
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
ATE207755T1 (de) 1998-04-30 2001-11-15 Vesely Renata Maria Cavaliere Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
NZ512275A (en) * 1998-12-11 2003-11-28 Urex Biotech Inc Probiotic therapy delivered to women by oral administration of selected lactobascilli that have antagonistic properties against urogenital pathogens
US20040197352A1 (en) * 1999-04-30 2004-10-07 Natarajan Ranganathan Methods of improving or augmenting kidney function
US7998470B2 (en) * 1999-04-30 2011-08-16 Kibow Biotech, Inc. Compositions and methods improving renal function
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US20020044926A1 (en) * 1999-12-10 2002-04-18 Gregor Reid Oral administration of lactobacillus for the treatment and prevention of urogenital infection
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
US6767537B2 (en) 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
US7913095B2 (en) * 2000-08-28 2011-03-22 Contentguard Holdings, Inc. Method and apparatus for providing a specific user interface in a system for managing content
RU2171672C1 (ru) * 2000-08-31 2001-08-10 Московская медицинская академия им. И.М. Сеченова Способ получения микрокапсулированных форм лактобактерий
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
RU2220716C1 (ru) * 2002-04-24 2004-01-10 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М.Сеченова Способ получения микрокапсул, содержащих живые микроорганизмы
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
MXPA06001821A (es) * 2003-08-18 2006-05-31 Bio Balance Corp Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.
US7132102B2 (en) * 2003-08-21 2006-11-07 The United States Of America As Represented By The Secretary Of Agriculture Bacteriocins and novel bacterial strains
JP5723080B2 (ja) 2003-09-30 2015-05-27 キボー バイオテック、インクＫｉｂｏｗ Ｂｉｏｔｅｃｈ， Ｉｎｃ． 腎臓機能を増大させるための組成物および方法
US20070009490A1 (en) * 2003-10-02 2007-01-11 Conte Anthony E Dried biotherapeutic composition, uses, and device and methods for administration thereof
CN101415389A (zh) * 2003-10-02 2009-04-22 生物平衡公司 干燥的生物治疗性组合物、其用途以及施用装置和方法
IE20030773A1 (en) 2003-10-17 2005-04-20 Teagasc Agric Food Dev Authori Use of probiotic bacteria in the treatment of infection
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050208034A1 (en) * 2004-03-17 2005-09-22 Jordan Lazonia V Natural vaginal yeast infection control
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
JP2008503563A (ja) * 2004-06-23 2008-02-07 ロレアル 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
EP1909844A1 (en) 2005-07-28 2008-04-16 The University of Hull Topical formulations containing sporopollenin
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
CN100382792C (zh) * 2005-09-12 2008-04-23 大连三仪动物药品有限公司 药用水溶性微胶囊及生产方法
US20070166295A1 (en) * 2006-01-13 2007-07-19 Vet Solutions L.P. Anti-Diarrhea Preparations for Small Domestic Animals
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
AR063304A1 (es) * 2006-10-13 2009-01-21 Gervais Danone Sa Nueva composicion para mejorar la calidad de la piel y proceso para preparar la misma
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
ES2322116B1 (es) 2007-03-12 2010-03-29 Consejo Superior Investig. Cientificas Microorganismo productor de anticuerpos, elementos necesarios para su obtencion, anticuerpos asi producidos, composiciones terapeuticas y sus aplicaciones.
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
ES2461791T3 (es) * 2007-09-04 2014-05-21 L'oréal Utilización de una combinación de hesperidina y de un microorganismo para actuar sobre la función de barrera de la piel
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
US8236297B2 (en) * 2007-10-11 2012-08-07 Kenneth Manzo Method of treating lactose intolerance using genetically engineered bacteria
US8642029B2 (en) * 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
KR100990765B1 (ko) 2008-06-13 2010-10-29 롯데쇼핑주식회사 락토바실러스 펜토서스 3090의 배양상등액을 함유하는항균제 조성물
GB0812513D0 (en) 2008-07-09 2008-08-13 Univ Hull Delivery vehicle
EP2158916A1 (en) * 2008-08-27 2010-03-03 Ellen Aktiebolag Administration unit comprising lactic acid bacteria
RU2440105C2 (ru) * 2009-01-15 2012-01-20 Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФБУН МНИИЭМ им. Г.Н. Габричевского Роспотребнадзора) Способ получения высокодисперсных биологически активных материалов
FR2942719B1 (fr) * 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
EP2243487A1 (en) 2009-04-23 2010-10-27 Actogenix N.V. Enteric coated formulation
CL2009001505A1 (es) * 2009-07-01 2009-09-25 Univ Concepcion Formulacion prebiotica de uso topico que comprende microesferas con composicion matricial a base de gelatina natural reticulada y una cepa probiotica viable de lactobacillus spp; proceso para generar dicha formulacion; uso de dicha formulacion para tratar lesiones de la piel.
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
DK2338476T3 (da) * 2009-12-02 2012-09-17 Bettina Heil Suppositorium til rektal, vaginal eller urethral indgivelse indeholdende et probiotikum, et antibiotikum og en umættet ikke-forestret fedtsyre
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
NL2004520C2 (en) * 2010-04-07 2011-10-11 Univ Delft Tech HEALING AGENT FOR SELF-HEALING CEMENTIOUS MATERIALS.
EP2667858B1 (en) 2011-01-25 2023-09-13 Austrianova Singapore Pte Ltd. Protection of microbial cells from acidic degradation
DE102011009798B4 (de) 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
CA2868362C (en) 2012-03-29 2018-07-31 Jerome Schentag Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
CN102613458B (zh) * 2012-04-16 2013-12-18 广东仙乐制药有限公司 一种益生菌软胶囊及其制备方法
US10130665B2 (en) 2012-05-18 2018-11-20 Genome Research Limited Method for identifying bacteria for bacteriotherapy
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
BR112015023124A2 (pt) 2013-03-14 2017-07-18 Therabiome Llc liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
KR101640744B1 (ko) 2014-05-07 2016-07-19 일동제약주식회사 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
TW201713775A (zh) 2015-06-25 2017-04-16 亞斯科生物科學公司 用於自複雜的異源群集中分析微生物品系、預測及識別其機能性關係及交互作用，且依據前述選擇並合成微生物系集之方法、裝置及系統
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10632157B2 (en) 2016-04-15 2020-04-28 Ascus Biosciences, Inc. Microbial compositions and methods of use for improving fowl production
RU2758109C2 (ru) * 2015-06-29 2021-10-26 Ферринг Б.В. Бактерия lactobacillus rhamnosus для лечения, например, бактериального вагиноза
CA3010505A1 (en) 2016-01-07 2017-07-13 Ascus Biosciences, Inc. Methods for improving milk production by administration of microbial consortia
CA3020833A1 (en) 2016-04-15 2017-10-19 Ascus Biosciences, Inc. Methods for improving agricultural production of fowl by administration of microbial consortia or purified strains thereof
KR102805966B1 (ko) * 2016-12-01 2025-05-12 주식회사 포스코 바이오프린팅 기술을 이용한 셀룰로오스 나노섬유 전달체 및 이를 이용한 선택적 방출 방법
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN110366596A (zh) 2016-12-28 2019-10-22 埃斯库斯生物科技股份公司 用于对复杂异质群落中的完整微生物株系进行分析、确定其功能关系及相互作用以及基于此来识别和合成生物活性改性剂的方法、设备和系统
CN110352250A (zh) 2016-12-28 2019-10-18 埃斯库斯生物科技股份公司 用于通过示踪剂分析法对复杂异质群落进行微生物株系分析、确定其功能关系及相互作用以及合成包括给药微生物群集和接种微生物群集的微生物群集的方法、设备和系统
WO2018201049A1 (en) 2017-04-28 2018-11-01 Ascus Biosciences, Inc. Methods for supporting grain intensive and/or energy intensive diets in ruminants with a synthetic bioensemble of microbes
US11825862B2 (en) 2017-10-18 2023-11-28 Native Microbials, Inc. Fowl production by administration of a synthetic bioensemble of microbes or purified strains thereof
RU2744839C1 (ru) * 2020-02-02 2021-03-16 Михаил Викторович Комаров Микроконтейнеры для защиты микроорганизмов, применяемые в сельском хозяйстве
CA3166211A1 (en) 2020-02-10 2021-08-19 Native Microbials, Inc. Microbial compositions and methods of use for canine enteropathy and dysbiosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4983163A (en) * 1981-10-09 1991-01-08 Science Research Center, Inc. Method, compositions and articles for prevention and treatment of herpes simplex virus infections
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
CN1057446C (zh) * 1993-02-02 2000-10-18 西安华誉技术发展有限公司 活性乳酸杆菌胶囊
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
UA39965C2 (uk) * 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )

Also Published As

Publication number Publication date
AR002754A1 (es) 1998-04-29
MX9709318A (es) 1998-02-28
ATE286737T1 (de) 2005-01-15
DE69634171T2 (de) 2006-01-19
CA2222642C (en) 2004-09-07
HUP9900682A2 (hu) 1999-06-28
IL118304A0 (en) 1996-09-12
DE69634171D1 (de) 2005-02-17
TW480174B (en) 2002-03-21
HUP9900682A3 (en) 2000-10-30
MY120501A (en) 2005-11-30
AU702799B2 (en) 1999-03-04
EP0828499B1 (en) 2005-01-12
US5614209A (en) 1997-03-25
PL323748A1 (en) 1998-04-14
JPH11506451A (ja) 1999-06-08
KR100478326B1 (ko) 2005-07-28
EA199700437A1 (ru) 1998-08-27
CN1100546C (zh) 2003-02-05
KR19990022220A (ko) 1999-03-25
US5633012A (en) 1997-05-27
US5733568A (en) 1998-03-31
NZ309456A (en) 2001-02-23
CN1192151A (zh) 1998-09-02
US5614209B1 (en) 1998-08-04
CA2222642A1 (en) 1996-12-05
AU5963196A (en) 1996-12-18
US5635202A (en) 1997-06-03
EA000412B1 (ru) 1999-06-24
IL118304A (en) 2000-08-13
EP0828499A1 (en) 1998-03-18
ZA963810B (en) 1997-01-03
WO1996038159A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
BR9609460A (pt) Lactobacilo microencapsulado para aplicações médicas
DK11395A (da) Spillemaskine
DE69623616D1 (de) Bandscheibenstabilisator
NO980833D0 (no) Absorberende produkter
FI955866A7 (fi) Poishuuhdeltavat vesi öljyssä vedessä -koostumukset
BR9600453A (pt) Suporte para monitor
IS4921A (is) Lækningatæki
PT1024854E (pt) Dispositivos de ligacao para fins medicos
DE19681009D2 (de) Reibeinheit
PT981334E (pt) Comprimido para engolir compreendendo paracetamol
BR9605702A (pt) Alourante para cabelos humanos
BR9500468A (pt) Dispositivo para transferência serial de objetos e sua aplicação
BR9609581A (pt) Dispositivo para aplicação de fluído
ES1033147Y (es) Dispositivo para la manipulacion de racimos de platanos.
DE69611426D1 (de) Reibungsverbindungsvorrichtung
DE69503368D1 (de) Dermatologisches präparat
FI940113A0 (fi) Aktiivinastajärjestelmä
BR9601229A (pt) Dispositivo para vedação
KR960030473U (ko) 병원용 베드헤드 유니트
NO963698D0 (no) Elastomer spröyte-aktiveringsinnretning
KR960004092U (ko) 완력기
NO943568D0 (no) Friksjonselement
KR950026736U (ko) 세면도구 살균 소독기
BR9302334A (pt) Urovarginal para pacientes
BR7400373U (pt) Dispositivo higiênico para aplicaçÃo específica

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law